Hughes Steven George bought RNA
August 6, 2025 · Form 4 insider transaction
Hughes Steven George bought 17,667 shares of Atrium Therapeutics, Inc. at $10.16 per share, a transaction worth $179.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,667
Price
$10.16
Total value
$179.5K
InsiderHughes Steven George
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 6, 2025
Filing dateAugust 8, 2025
Shares owned after90,517
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.